Search
for
Sort by
Research 121–150 of 320
- Skin Disorders in Athletes: Professional and Recreational Sports
- Cutaneous Lupus Erythematosus
- Cutaneous manifestations of systemic infection in children
- Cutaneous signals of immune system disease
- A study of cutaneous manifestations of systemic lupus erythematosus in Malwa region of India
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Tinea Capitis Kerion Type: A Case Report
- Oral Retinoids in Dermatology
- Parkinson's disease and skin
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Non-hemorrhage-related adverse effects of rivaroxaban
- An overview of zinc and its importance in dermatology-Part II: The association of zinc with some dermatologic disorders
- Diseases of Periocular Hair
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Editorial: Prevention and treatment of skin diseases
- Dermatological manifestations and associated factors in patients with Graves\' disease in Dakar
- Dermatological Manifestations of COVID-19: A Brief Review
- Scaly Papular Lesions
- Cutaneous Lupus Erythematosus
- Fever and rash as initial signs of systemic autoimmune disease. Case Report.
- Indirect skin sign of COVID‐19 days: Striae rubrae
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- A Study of Cutaneous Manifestations in Patients During the Post-COVID Period in A Tertiary Care Center
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- The COVID-19 pandemic and its skin effects